Envestnet Asset Management
UTHR icon

Envestnet Asset Management’s United Therapeutics UTHR Stock Holding History

Envestnet Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2M Sell
35,362
-6,768
-16% -$3.81M ﹤0.01% 1482
2026
Q1 		$25M Buy
42,130
+2,829
+7% +$1.41M 0.01% 1198
2025
Q4 		$19.1M Sell
39,301
-18,519
-32% -$8.62M 0.01% 1238
2025
Q3 		$24.2M Sell
57,820
-15,252
-21% -$5.13M 0.01% 1150
2025
Q2 		$21M Buy
73,072
+1,163
+2% +$348K 0.01% 1228
2025
Q1 		$22.2M Buy
71,909
+11,029
+18% +$3.78M 0.01% 1131
2024
Q4 		$21.5M Buy
60,880
+2,889
+5% +$1.06M 0.01% 1156
2024
Q3 		$20.8M Buy
57,991
+9,010
+18% +$3.04M 0.01% 1161
2024
Q2 		$15.6M Buy
48,981
+5,531
+13% +$1.46M 0.01% 1269
2024
Q1 		$9.98M Sell
43,450
-2,509
-5% -$566K ﹤0.01% 1526
2023
Q4 		$10.1M Buy
45,959
+421
+0.9% +$97K ﹤0.01% 1441
2023
Q3 		$10.3M Sell
45,538
-7,656
-14% -$1.76M ﹤0.01% 1356
2023
Q2 		$11.7M Sell
53,194
-482,990
-90% -$107M 0.01% 1203
2023
Q1 		$11.8M Buy
536,184
+477,636
+816% +$118M 0.01% 1153
2022
Q4 		$16.3M Buy
58,548
+8,327
+17% +$2.1M 0.01% 957
2022
Q3 		$10.5M Sell
50,221
-496
-1% -$111K 0.01% 1101
2022
Q2 		$12M Sell
50,717
-10,921
-18% -$2.22M 0.01% 1054
2022
Q1 		$11.1M Buy
61,638
+2,088
+4% +$398K 0.01% 1148
2021
Q4 		$12.9M Buy
59,550
+4,743
+9% +$931K 0.01% 1063
2021
Q3 		$10.1M Buy
54,807
+39,325
+254% +$7.75M 0.01% 1145
2021
Q2 		$2.78M Buy
15,482
+2,180
+16% +$415K ﹤0.01% 1856
2021
Q1 		$2.23M Buy
13,302
+2,647
+25% +$441K ﹤0.01% 1870
2020
Q4 		$1.62M Sell
10,655
-1,857
-15% -$244K ﹤0.01% 1886
2020
Q3 		$1.26M Sell
12,512
-1,690
-12% -$185K ﹤0.01% 1878
2020
Q2 		$1.72M Buy
14,202
+11,652
+457% +$1.31M ﹤0.01% 1662
2020
Q1 		$242K Sell
2,550
-7,289
-74% -$693K ﹤0.01% 2655
2019
Q4 		$867K Buy
9,839
+874
+10% +$76.9K ﹤0.01% 2120
2019
Q3 		$715K Buy
8,965
+1,863
+26% +$150K ﹤0.01% 2166
2019
Q2 		$554K Buy
7,102
+230
+3% +$21.5K ﹤0.01% 2337
2019
Q1 		$807K Buy
6,872
+4,259
+163% +$496K ﹤0.01% 2023
2018
Q4 		$285K Buy
+2,613
New +$303K ﹤0.01% 2456
2018
Q3 		– Sell
-857
Closed -$96K – 2566
2018
Q2 		$96K Sell
857
-12
-1% -$1.32K ﹤0.01% 1994
2018
Q1 		$97K Sell
869
-140
-14% -$17.8K ﹤0.01% 1924
2017
Q4 		$149K Sell
1,009
-7,502
-88% -$954K ﹤0.01% 1968
2017
Q3 		$997K Buy
8,511
+7,085
+497% +$905K ﹤0.01% 1166
2017
Q2 		$182K Sell
1,426
-962
-40% -$120K ﹤0.01% 1907
2017
Q1 		$322K Sell
2,388
-3,321
-58% -$503K ﹤0.01% 1733
2016
Q4 		$819K Buy
5,709
+836
+17% +$107K ﹤0.01% 1261
2016
Q3 		$575K Sell
4,873
-1,998
-29% -$240K ﹤0.01% 1494
2016
Q2 		$728K Buy
6,871
+1,592
+30% +$178K ﹤0.01% 1481
2016
Q1 		$588K Buy
5,279
+432
+9% +$54.7K ﹤0.01% 1564
2015
Q4 		$759K Buy
4,847
+171
+4% +$24.9K ﹤0.01% 1415
2015
Q3 		$614K Sell
4,676
-33
-0.7% -$5.29K ﹤0.01% 1505
2015
Q2 		$819K Sell
4,709
-434
-8% -$78.1K ﹤0.01% 1491
2015
Q1 		$887K Buy
5,143
+4,159
+423% +$634K ﹤0.01% 1340
2014
Q4 		$127K Sell
984
-211
-18% -$27.2K ﹤0.01% 1115
2014
Q3 		$154K Sell
1,195
-213
-15% -$22K ﹤0.01% 1170
2014
Q2 		$125K Sell
1,408
-210
-13% -$20.2K ﹤0.01% 1144
2014
Q1 		$152K Sell
1,618
-68
-4% -$6.96K ﹤0.01% 1000
2013
Q4 		$191K Buy
1,686
+149
+10% +$13.4K ﹤0.01% 837
2013
Q3 		$121K Buy
1,537
+542
+54% +$39.6K ﹤0.01% 926
2013
Q2 		$65K Buy
+995
New +$64.1K ﹤0.01% 1114

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Envestnet Asset Management's UTHR Position: Q2 2026 in Review

Envestnet Asset Management reduced its United Therapeutics (UTHR) stake by 16% in Q2 2026, selling an estimated $3.81M and leaving 35,362 shares worth $19.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1482.

Envestnet Asset Management first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. The position peaked at $25M in Q1 2026. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Envestnet Asset Management held 35,362 shares of United Therapeutics worth $19.2M as of Q2 2026.
  • Envestnet Asset Management sold 6,768 United Therapeutics shares in Q2 2026, an estimated $3.81M.
  • United Therapeutics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1482 holding.
  • Envestnet Asset Management first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • Envestnet Asset Management's United Therapeutics position peaked at $25M in Q1 2026.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.